{"cluster": 26, "subcluster": 1, "abstract_summ": "Abstract In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand.As cardiologists and cardiovascular service lines will be heavily involved in the care of patients with COVID-19, our division organized an approach to manage these complications, attempting to balance resource utilization and risk to personnel with optimal cardiovascular care.In this article we provide guidance on the management of cardiac patients without COVID-19 in the current pandemic as well as patients with cardiac disease and COVID-19 and patients with cardiac complications of COVID-19.Protection of health care personnel from contracting the disease should be given high priority.\u2022 Ischemic cardiovascular disease continues to be most common cause of death after age 55 everywhere in the world.It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes.", "title_summ": ": Insights from an institutional responsePatients with Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus StatementCardiological Society of India: Document on Acute MI care during COVID-19()Cardiological society of India position statement on COVID-19 and heart failurePreventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) futureCardiovascular Considerations for the Internist and Hospitalist in the COVID-19 EraTesting cardiovascular autonomic function in the COVID-19 era: lessons from Bologna\u2019s Autonomic UnitCardiac workup and monitoring in hospitalised children with COVID- 19.SARS-CoV-2 pandemic and the cardiovascular system: What the non-cardiologist needs to know.CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic #Autonomic function testing in the COVID-19 pandemic: an American Autonomic Society position statementA care pathway for the cardiovascular complications of COVID-19", "title_abstract_phrases": "As cardiologists and cardiovascular service lines will be heavily involved in the care of patients with COVID-19, our division organized an approach to manage these complications, attempting to balance resource utilization and risk to personnel with optimal cardiovascular care.In this article we provide guidance on the management of cardiac patients without COVID-19 in the current pandemic as well as patients with cardiac disease and COVID-19 and patients with cardiac complications of COVID-19.Patients with Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus StatementAbstract In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand.Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 EraIt is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes.Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna\u2019s Autonomic UnitThe coronavirus disease 2019 (COVID-19) pandemic has changed the way most medical procedures are performed."}